Product NDC: | 55390-503 |
Proprietary Name: | Alprostadil |
Non Proprietary Name: | Alprostadil |
Active Ingredient(s): | 500 ug/mL & nbsp; Alprostadil |
Administration Route(s): | INTRAVASCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-503 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074815 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050304 |
Package NDC: | 55390-503-10 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-503-10) > 1 mL in 1 VIAL |
NDC Code | 55390-503-10 |
Proprietary Name | Alprostadil |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-503-10) > 1 mL in 1 VIAL |
Product NDC | 55390-503 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Alprostadil |
Dosage Form Name | INJECTION |
Route Name | INTRAVASCULAR; INTRAVENOUS |
Start Marketing Date | 20050304 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | ALPROSTADIL |
Strength Number | 500 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |